Clinical Trials in Arizona

Showing 5201-5220 of 16,770 trials

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

NCT04294225

This phase II trial studies how well anastrozole and letrozole after surgery work in treating patients with stage I-III breast cancer. Drugs, such as anastrozole and letrozole, may stop the growth of tumor cells by decreasing the amount of estrogen made by the body. Giving anastrozole and letrozole after surgery may prevent breast cancer from coming back (recurrence).

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more

Mayo Clinic161 participantsStarted Apr 2020

Scottsdale, Arizona, United States • Jacksonville, Florida, United States • Rochester, Minnesota, United States

TERMINATEDPhase 238 miles

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

NCT05113966

This was a Phase 2, multicenter, open-label, single-arm study evaluating the safety and efficacy of trilaciclib administered prior to sacituzumab govitecan-hziy in participants with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received at least 2 prior treatments, at least 1 in the metastatic setting.

Triple Negative Breast Cancer

G1 Therapeutics, Inc.30 participantsStarted Dec 2021

Chandler, Arizona, United States • Bakersfield, California, United States • Los Angeles, California, United States +19 more locations

Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer

Trilaciclib in Patients Receiving Sacituzumab Govitecan-hziy for Triple Negative Breast Cancer

Find Trials by Condition in Arizona

Coordinated, Collaborative, Comprehensive, Family-based, Integrated, Technology-enabled Stroke Care

PhII ICb With/Without Erbitux in MBC Pts

Avelumab in First-line NSCLC (JAVELIN Lung 100)

A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)

The INSPIRE-ASP PNA Trial

Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium

HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy

Assess the Safety, Tolerability and Efficacy of Latanoprost Liposome for Lower Eyelid Steatoblepharon

Phase 2 Platform Study in Patients With Advanced Non-Small Lung Cancer Who Progressed on First-Line Osimertinib Therapy (ORCHARD)

A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers

Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF)

Phase 1, Open-label, Single Dose Study to Examine Safety, Tolerability, Pharmacokinetics and Virologic Impact of VRC01LS or VRC07-523LS in HIV-infected Viremic Adults

Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

Early Feasibility Evaluation of the AccuCinch® Ventricular Restoration System in Patients With Heart Failure and Reduced Ejection Fraction

The CorCinch - Functional Mitral Valve Regurgitation (FMR) Study

Study of the Safety, Tolerability, Pharmacokinetics and Biomarker of DONQ52 in Celiac Disease Patients

Plasma Resuscitation Without Lung Injury

A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion